世界のオーソバイオロジクス市場2022ー2031:製品別(骨形成タンパク質、脱灰骨基質、合成骨代替物、粘性サプリメント、同種移植片、幹細胞)

【英語タイトル】Orthobiologics Market (Product: Bone Morphogenetic Proteins, Demineralized Bone Matrix, Synthetic Bone Substitutes, Viscosupplements, Allografts, and Stem Cell) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Transparency Market Researchが出版した調査資料(TMR22AU0043)・商品コード:TMR22AU0043
・発行会社(調査会社):Transparency Market Research
・発行日:2022年6月
・ページ数:251
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後24時間以内)
・調査対象地域:グローバル
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD5,795 ⇒換算¥811,300見積依頼/購入/質問フォーム
Multi User(5名様閲覧)USD8,795 ⇒換算¥1,231,300見積依頼/購入/質問フォーム
Corporate License(法人閲覧)USD11,795 ⇒換算¥1,651,300見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
Transparency Market Research社の当調査資料では、世界のオーソバイオロジクス市場について広く調査・分析を行い、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、キーインサイト、製品別(脱灰骨基質、同種移植片、人工骨代替物、粘性補助剤、骨形成タンパク質)分析、用途別分析、エンドユーザー別分析、地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ)分析、競争状況などをまとめました。なお、当書に掲載されている企業情報には、Alphatec Spine, Inc.、Arthrex、Bioventus、DePuy Synthes、Exactech, Inc.、Globus Medical, Inc.、Integra Life Sciences、Johnson & Johnson、Medtronic plc、MTF Biologics、RTI Surgical, Inc.、Sanofi、Stryker、Zimmer Biometなどが含まれています。
・序論
・仮定・調査手法
・エグゼクティブサマリー
・市場概要
・キーインサイト
・世界のオーソバイオロジクス市場規模:製品別(脱灰骨基質、同種移植片、人工骨代替物、粘性補助剤、骨形成タンパク質)
・世界のオーソバイオロジクス市場規模:用途別
・世界のオーソバイオロジクス市場規模:エンドユーザー別
・世界のオーソバイオロジクス市場規模:地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ)
・競争状況
❖ レポートの概要 ❖

Orthobiologics Market – Scope of Report

TMR’s report on the global orthobiologics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global orthobiologics market for the period 2017–2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global orthobiologics market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the orthobiologics market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global orthobiologics market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global orthobiologics market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global orthobiologics market.

The report delves into the competitive landscape of the global orthobiologics market. Key players operating in the global orthobiologics market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global orthobiologics market profiled in this report.

RESEARCH METHODOLOGY

The research methodology will be a combination of exhaustive primary and secondary research to analyze the market orthobiologics.

Secondary Research

Secondary research includes a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.

Secondary research sources that we typically refer, but are not limited to:

Company websites, presentations, annual reports, white papers, technical paper, product brochure
Internal and external proprietary databases and relevant patents
National government documents, statistical databases, and market reports
News articles, press releases, and webcasts specific to companies operating in the market

Specific Secondary Sources:

Industry Sources:
WorldWideScience.org
Elsevier, Inc.
National Institutes of Health (NIH)
PubMed
NCBI
Department of Health Care Service
Trade Data Sources
Trade Map
UN Comtrade
Trade Atlas
Company Information
OneSource Business Browser
Hoover’s
Factiva
Bloomberg
Mergers & Acquisitions
Thomson Mergers & Acquisitions
MergerStat
Profound

Primary Research

During the course of research, we conduct in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents bulk of research efforts, supplemented by extensive secondary research.

We conduct primary interviews on the ongoing basis with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:

Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
Helps in validating and strengthening secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies

Participants who typically take part in such a process include, but are not limited to:

Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
Purchasing/Sourcing managers, technical personnel, distributors
Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry verticals

List of primary participants, but not limited to:

Advanced Oncotherapy PLC
Danfysik A/S
Hitachi, Ltd.
IBA Worldwide
Mevion Medical Systems, Inc.

Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with “TMR Knowledge Repository”, which is updated every quarter.

Market Estimation: Market size estimations involved in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we employed modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:

Demographic Data: Healthcare expenditure, inflation rates, and others
Industry Indicators: R&D investment, technology stage, and infrastructure, sector growth, and facilities

Market Forecasting: Market forecasts for various segments are derived taking into account drivers, restraints/challenges, and opportunities prevailing in the market and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise surgery data are some of the other pivotal factors, which are considered to derive market forecasts.

❖ レポートの目次 ❖

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Orthobiologics Market
4. Market Overview
4.1. Introduction
4.1.1. Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Orthobiologics Market Analysis and Forecast, 2017–2031
5. Key Insights
5.1. Key Market Trends
5.2. Merger and Acquisition
5.3. Strategies of Top Five Players Operating in the Market
5.4. Incidence of Orthopedic Disorder, by Key Countries
5.5. Regulatory and Reimbursement Scenario, by Key Countries
6. Global Orthobiologics Market Analysis and Forecast, by Product
6.1. Introduction & Definition
6.2. Market Value Forecast, by Product, 2017–2031
6.2.1. Demineralized Bone Matrix
6.2.2. Allografts
6.2.3. Synthetic Bone Substitutes
6.2.4. Viscosupplements
6.2.5. Bone Morphogenetic Proteins
6.2.6. Stem Cell Therapy
6.2.7. Others
6.3. Market Attractiveness, by Product
7. Global Orthobiologics Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Market Value Forecast, by Application, 2017–2031
7.2.1. Spinal Fusion
7.2.2. Trauma Repair
7.2.3. Reconstructive Surgeries
7.2.4. Others
7.3. Market Attractiveness Analysis, by Application
8. Global Orthobiologics Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Market Value Forecast, by End-user, 2017–2031
8.2.1. Hospitals
8.2.2. Orthopedic Clinics
8.2.3. Others
8.3. Market Attractiveness Analysis, by End-user
9. Global Orthobiologics Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Orthobiologics Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product, 2017–2031
10.2.1. Demineralized Bone Matrix
10.2.2. Allografts
10.2.3. Synthetic Bone Substitutes
10.2.4. Viscosupplements
10.2.5. Bone Morphogenetic Proteins
10.2.6. Stem Cell Therapy
10.2.7. Others
10.3. Market Value Forecast, by Application, 2017–2031
10.3.1. Spinal Fusion
10.3.2. Trauma Repair
10.3.3. Reconstructive Surgeries
10.3.4. Others
10.4. Market Value Forecast, by End-user, 2017–2031
10.4.1. Hospitals
10.4.2. Orthopedic Clinics
10.4.3. Others
10.5. Market Value Forecast, by Country, 2017–2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Product
10.6.2. By Application
10.6.3. By End-user
10.6.4. By Country
11. Europe Orthobiologics Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product, 2017–2031
11.2.1. Demineralized Bone Matrix
11.2.2. Allografts
11.2.3. Synthetic Bone Substitutes
11.2.4. Viscosupplements
11.2.5. Bone Morphogenetic Proteins
11.2.6. Stem Cell Therapy
11.2.7. Others
11.3. Market Value Forecast, by Application, 2017–2031
11.3.1. Spinal Fusion
11.3.2. Trauma Repair
11.3.3. Reconstructive Surgeries
11.3.4. Others
11.4. Market Value Forecast, by End-user, 2017–2031
11.4.1. Hospitals
11.4.2. Orthopedic Clinics
11.4.3. Others
11.5. Market Value Forecast, by Country/Sub-region, 2017–2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Product
11.6.2. By Application
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Orthobiologics Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product, 2017–2031
12.2.1. Demineralized Bone Matrix
12.2.2. Allografts
12.2.3. Synthetic Bone Substitutes
12.2.4. Viscosupplements
12.2.5. Bone Morphogenetic Proteins
12.2.6. Stem Cell Therapy
12.2.7. Others
12.3. Market Value Forecast, by Application, 2017–2031
12.3.1. Spinal Fusion
12.3.2. Trauma Repair
12.3.3. Reconstructive Surgeries
12.3.4. Others
12.4. Market Value Forecast, by End-user, 2017–2031
12.4.1. Hospitals
12.4.2. Orthopedic Clinics
12.4.3. Others
12.5. Market Value Forecast, by Country/Sub-region, 2017–2031
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Product
12.6.2. By Application
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Orthobiologics Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product, 2017–2031
13.2.1. Demineralized Bone Matrix
13.2.2. Allografts
13.2.3. Synthetic Bone Substitutes
13.2.4. Viscosupplements
13.2.5. Bone Morphogenetic Proteins
13.2.6. Stem Cell Therapy
13.2.7. Others
13.3. Market Value Forecast, by Application, 2017–2031
13.3.1. Spinal Fusion
13.3.2. Trauma Repair
13.3.3. Reconstructive Surgeries
13.3.4. Others
13.4. Market Value Forecast, by End-user, 2017–2031
13.4.1. Hospitals
13.4.2. Orthopedic Clinics
13.4.3. Others
13.5. Market Value Forecast, by Country/Sub-region, 2017–2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Product
13.6.2. By Application
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Orthobiologics Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product, 2017–2031
14.2.1. Demineralized Bone Matrix
14.2.2. Allografts
14.2.3. Synthetic Bone Substitutes
14.2.4. Viscosupplements
14.2.5. Bone Morphogenetic Proteins
14.2.6. Stem Cell Therapy
14.2.7. Others
14.3. Market Value Forecast, by Application, 2017–2031
14.3.1. Spinal Fusion
14.3.2. Trauma Repair
14.3.3. Reconstructive Surgeries
14.3.4. Others
14.4. Market Value Forecast, by End-user, 2017–2031
14.4.1. Hospitals
14.4.2. Orthopedic Clinics;
14.4.3. Others
14.5. Market Value Forecast, by Country/Sub-region, 2017–2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Product
14.6.2. By Application
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player – Competitive Matrix (by tier and size of companies)
15.2. Market Share Analysis, by Company (2021)
15.3. Company Profiles
15.3.1. Medtronic
15.3.1.1. Company Overview
15.3.1.2. Product Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Financial Overview
15.3.1.5. Strategic Overview
15.3.2. DePuy Synthes (Johnson & Johnson)
15.3.2.1. Company Overview
15.3.2.2. Product Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Financial Overview
15.3.2.5. Strategic Overview
15.3.3. Sanofi
15.3.3.1. Company Overview
15.3.3.2. Product Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Financial Overview
15.3.3.5. Strategic Overview
15.3.4. Seikagaku Corporation
15.3.4.1. Company Overview
15.3.4.2. Product Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Financial Overview
15.3.4.5. Strategic Overview
15.3.5. Stryker
15.3.5.1. Company Overview
15.3.5.2. Product Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Financial Overview
15.3.5.5. Strategic Overview
15.3.6. MTF Biologics
15.3.6.1. Company Overview
15.3.6.2. Product Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Financial Overview
15.3.6.5. Strategic Overview
15.3.7. Bioventus LLC
15.3.7.1. Company Overview
15.3.7.2. Product Portfolio
15.3.7.3. SWOT Analysis
15.3.7.4. Financial Overview
15.3.7.5. Strategic Overview
15.3.8. Arthrex
15.3.8.1. Company Overview
15.3.8.2. Product Portfolio
15.3.8.3. SWOT Analysis
15.3.8.4. Financial Overview
15.3.8.5. Strategic Overview
15.3.9. Zimmer Biomet
15.3.9.1. Company Overview
15.3.9.2. Product Portfolio
15.3.9.3. SWOT Analysis
15.3.9.4. Financial Overview
15.3.9.5. Strategic Overview
15.3.10. RTI Surgical, Inc.
15.3.10.1. Company Overview
15.3.10.2. Product Portfolio
15.3.10.3. SWOT Analysis
15.3.10.4. Financial Overview
15.3.10.5. Strategic Overview
15.3.11. Alphatec Spine, Inc.
15.3.11.1. Company Overview
15.3.11.2. Product Portfolio
15.3.11.3. SWOT Analysis
15.3.11.4. Financial Overview
15.3.11.5. Strategic Overview
15.3.12. Exactech, Inc.
15.3.12.1. Company Overview
15.3.12.2. Product Portfolio
15.3.12.3. SWOT Analysis
15.3.12.4. Financial Overview
15.3.12.5. Strategic Overview
15.3.13. Globus Medical, Inc.
15.3.13.1. Company Overview
15.3.13.2. Product Portfolio
15.3.13.3. SWOT Analysis
15.3.13.4. Financial Overview
15.3.13.5. Strategic Overview
15.3.14. Integra LifeSciences
15.3.14.1. Company Overview
15.3.14.2. Product Portfolio
15.3.14.3. SWOT Analysis
15.3.14.4. Financial Overview
15.3.14.5. Strategic Overview

List of Tables

Table 01: Global Orthobiologics Market Size (US$ Mn) Forecast, by Product, 2017–2031

Table 02: Global Orthobiologics Market Size (US$ Mn) Forecast, by Application, 2017–2031

Table 03: Global Orthobiologics Market Size (US$ Mn) Forecast, by End-user, 2017–2031

Table 04: Global Orthobiologics Market Size (US$ Mn) Forecast, by Region, 2017–2031

Table 05: North America Orthobiologics Market Size (US$ Mn) Forecast, by Country, 2017–2031

Table 06: North America Orthobiologics Market Size (US$ Mn) Forecast, by Product, 2017–2031

Table 07: North America Orthobiologics Market Size (US$ Mn) Forecast, by Application, 2017–2031

Table 08: North America Orthobiologics Market Size (US$ Mn) Forecast, by End-user, 2017–2031

Table 09: Europe Orthobiologics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 10: Europe Orthobiologics Market Size (US$ Mn) Forecast, by Product, 2017–2031

Table 11: Europe Orthobiologics Market Size (US$ Mn) Forecast, by Application, 2017–2031

Table 12: Europe Orthobiologics Market Size (US$ Mn) Forecast, by End-user, 2017–2031

Table 13: Asia Pacific Orthobiologics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 14: Asia Pacific Orthobiologics Market Size (US$ Mn) Forecast, by Product, 2017–2031

Table 15: Asia Pacific Orthobiologics Market Size (US$ Mn) Forecast, by Application, 2017–2031

Table 16: Asia Pacific Orthobiologics Market Size (US$ Mn) Forecast, by End-user, 2017–2031

Table 17: Latin America Orthobiologics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 18: Latin America Orthobiologics Market Size (US$ Mn) Forecast, by Product, 2017–2031

Table 19: Latin America Orthobiologics Market Size (US$ Mn) Forecast, by Application, 2017–2031

Table 20: Latin America Orthobiologics Market Size (US$ Mn) Forecast, by End-user, 2017–2031

Table 21: Middle East & Africa Orthobiologics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 22: Middle East & Africa Orthobiologics Market Size (US$ Mn) Forecast, by Product, 2017–2031

Table 23: Middle East & Africa Orthobiologics Market Size (US$ Mn) Forecast, by Application, 2017–2031

Table 24: Middle East & Africa Orthobiologics Market Size (US$ Mn) Forecast, by End-user, 2017–2031

★調査レポート[世界のオーソバイオロジクス市場2022ー2031:製品別(骨形成タンパク質、脱灰骨基質、合成骨代替物、粘性サプリメント、同種移植片、幹細胞)] (コード:TMR22AU0043)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のオーソバイオロジクス市場2022ー2031:製品別(骨形成タンパク質、脱灰骨基質、合成骨代替物、粘性サプリメント、同種移植片、幹細胞)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆